Cerebral Blood Flow Measured with 3D Pseudocontinuous Arterial Spin-labeling MR Imaging in Alzheimer Disease and Mild Cognitive Impairment: A Marker for Disease Severity

Authors:
  • JKJoost P. A. Kuijer
    Joost P. A. Kuijer
  • MBMarije R. Benedictus
    Marije R. Benedictus
  • WFWiesje M. van der Flier
    Wiesje M. van der Flier
  • AWAlle Meije Wink
    Alle Meije Wink
  • MWMike P. Wattjes
    Mike P. Wattjes
  • BBBart N. M. van Berckel
    Bart N. M. van Berckel
  • PSPhilip Scheltens
    Philip Scheltens
  • FBFrederik Barkhof
    Frederik Barkhof

Abstract
Quantitative cerebral blood flow measured with three-dimensional pseudocontinuous arterial spin-labeling MR imaging helps detect functional brain injury caused by Alzheimer disease pathology both in the prodromal and more advanced stages of the disease; its relationship to cognition indicates the clinical relevance of this functional marker. PurposeTo compare quantitative cerebral blood flow (CBF) values in patients with Alzheimer disease (AD), patients with mild cognitive impairment (MCI), and subjects with subjective complaints by using a whole-brain three-dimensional (3D) pseudocontinuous arterial spin-labeling (ASL) technique at 3.0 T.Materials and MethodsThe local institutional review board approved the study. All subjects provided informed consent. Whole-brain 3D fast spin-echo pseudocontinuous ASL images were acquired at 3.0 T in 71 patients with AD (mean age, 65 years ± 7; 55% women), 35 patients with MCI (mean age, 65 years ± 8; 42% women), and 73 subjects with subjective complaints (mean age, 60 years ± 9; 39% women) who visited a memory clinic. Analyses were performed by using both uncorrected maps and maps corrected for partial volume effects. Regional CBF was compared by using analyses of variance; permutation tests were used for voxel-wise comparisons. Associations with cognition (Mini-Mental State Examination) were investigated...

This publication has 29 references indexed in Scilit: